Archives
-
TRPV1, TRPA1, and TSLP in Nasal Epithelium
2026-09-10
The reference study identifies a calcium/NFAT mechanism linking TRPV1 and TRPA1 activation in nasal epithelial cells to TSLP production. Its findings clarify how temperature- and irritant-sensitive ion channels may contribute to upper-airway inflammation and provide a mechanistic framework for epithelial and sensory ion-channel assays.
-
Mecamylamine Hydrochloride in Gut-Brain Circuit Tests
2026-09-10
Mecamylamine hydrochloride provides a pharmacological stress test for nicotinic signaling in microbiota–vagus–brain experiments. This article translates recent Bacteroides fragilis findings into practical assay decisions while defining what a nonselective antagonist can—and cannot—prove.
-
Liproxstatin-1 HCl: Ferroptosis Assay Guide
2026-09-09
Liproxstatin-1 HCl enables pathway-selective rescue experiments that distinguish ferroptosis from apoptosis and nonspecific oxidative injury. This guide translates its lipid-peroxidation inhibition into practical workflows for cell assays, acute renal failure models, hepatic ischemia/reperfusion injury, and mitochondrial calcium studies.
-
X-press Tag Peptide for RHEB Assay Design
2026-09-09
X-press Tag Peptide can turn recombinant RHEB purification into a more interpretable assay workflow. This guide connects its polyhistidine, Xpress epitope, and enterokinase features to mechanistic validation of RHEB neddylation and mTORC1 signaling.
-
Targeted Amikacin Delivery into Mycobacterial Granulomas
2026-09-08
Montes-Worboys and colleagues developed a dendritic-cell delivery strategy that transported fluorescently labeled amikacin into granulomas in Mycobacterium avium–infected mice. The study supports targeted localization as a potential adjunct to systemic therapy, while also showing why fluorescent conjugates, inflammatory markers, and disease-model limitations must be considered before translation.
-
Bacillus Strains Shape γ-Glutamyl Peptide Production
2026-09-07
This study systematically compares six Bacillus strains in brain heart infusion and hemoglobin hydrolysate media to determine how organism choice and substrate environment influence γ-glutamyl peptide production. Its central practical finding is that medium composition often had a stronger effect than strain identity, providing a useful framework for fermentation-based kokumi peptide production and for interpreting glutathione-related outputs.
-
Metabolomics Reveals Carbapenemase Resistance
2026-09-07
A 2025 study used LC-MS/MS metabolomics and supervised machine learning to distinguish carbapenemase-producing from non-producing Enterobacterales in antibiotic-free cultures. Its metabolite signatures provide mechanistic clues about resistance and a possible route toward faster diagnostics than conventional culture-based workflows.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-09-05
This Cancer Letters review integrates tumor hypoxia, metabolic reprogramming, and immune-cell dysfunction into a feedback model of immunosuppressive tumor-microenvironment formation. Its practical value lies in showing why tumor metabolism and immune metabolism should be studied together when evaluating therapeutic strategies and redox-associated biomarkers.
-
8-Chloroadenosine for RNA Regulation Workflows
2026-09-04
8-Chloroadenosine provides a practical chemical perturbation for separating RNA production from RNA stability in cell-based experiments. This workflow links transcriptional inhibition with the RP3-340N1.2–IL-6 axis, helping researchers design stronger RNA metabolism studies and cancer research assays.
-
Bestatin and Actinonin in Myeloma Cell Proliferation
2026-09-04
The reference study separates cell-surface aminopeptidase inhibition from the antiproliferative effects of bestatin and actinonin. By using drug-efflux modifiers, it provides pharmacological evidence that intracellular exposure, regulated by MRP and P-glycoprotein, is central to inhibitor activity in U937 and K562 cells.
-
SB 431542 Workflows for ALK5 Inhibition
2026-09-04
SB 431542 is a selective ALK5 inhibitor for dissecting TGF-β/Smad2 signaling in cancer, immune, and stem-cell-derived neuronal models. This workflow-focused guide shows how to connect pathway validation with a scalable human sensory-neuron system for HSV-1 latency research while keeping compound effects distinct from neuronal and viral phenotypes.
-
Biomimetic Models of Lung Drug Permeability
2026-09-03
The reference study compares immobilised artificial membrane liquid chromatography and open-tubular capillary electrochromatography, each coupled with mass spectrometry, as biomimetic tools for modelling pulmonary drug permeability. Its findings show that the methods are complementary: IAM-LC more closely reflects conventional partitioning and permeability behavior, whereas OT-CEC provides additional information about phospholipid composition and drug–membrane interactions.
-
Self-Amplifying RNA Vaccines for Influenza
2026-09-02
A 2026 study found that low-dose self-amplifying RNA vaccines overcame a major immunogenicity problem observed with influenza B antigens in conventional mRNA formulations. In mice, trivalent saRNA generated durable antibody responses and complete protection against influenza B challenge, highlighting a dose-sparing strategy that remains to be validated beyond preclinical models.
-
From Proteomics to Signal: Validating HMGB1
2026-09-02
Translational biomarker programs must connect discovery-scale proteomics with sensitive, spatially resolved validation. This thought-leadership article examines how the FITC Goat Anti-Rabbit IgG (H+L) Antibody can strengthen HMGB1 validation workflows in diabetic nephropathy research through mechanistic signal amplification, disciplined controls, and strategic assay selection.
-
Cyanine 3 Tyramide for Neural Circuit Assays
2026-09-01
Cyanine 3 Tyramide provides localized signal amplification for low-abundance targets in neuroscience assays. This article translates recent oxytocin-circuit findings into practical IHC and ISH assay decisions while clarifying workflow limits and controls.